Genesis Molecular AI
Genesis Molecular AI is building a top-tier computational chemistry team focused on revolutionizing drug discovery through machine learning and biophysical simulations. They are hiring a Principal CADD Scientist to collaborate with scientists in laboratory and computational settings, driving innovative approaches in small molecule drug design.
Genesis Molecular AI is a biotechnology company delivering the industry’s most advanced molecular AI platform to unlock tough protein targets and accelerate drug discovery at scale. Its platform combines AI-driven analytics with molecular understanding to identify viable targets and design candidate medicines more efficiently. The solution is tailored for biotech and pharmaceutical teams seeking scalable, data-driven discovery workflows that shorten preclinical timelines. Genesis positions itself as a leader in AI-enabled drug discovery, helping researchers move faster from target to medicine.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genesis Molecular AI.
9% above the average for this role
Scientist, Computational Chemistry, Drug Discovery
Lila Sciences
Principal Scientist, Computational Chemistry
Cytokinetics
VP Head of Therapeutics Design
Evotec
Senior Scientist, Computational Chemistry
lifelancer
Senior Scientist, Computational Chemistry
Vertex
Principal Scientist - Computational Chemistry
Pfizer